107 related articles for article (PubMed ID: 4051516)
1. [Effects of combination chemotherapy M-VEMFH including mitoxantrone in advanced breast cancer].
Ito Y; Hoshino A; Ohara K; Kamiya O; Nagata K; Kojima T; Kinoshita T; Sugiura I
Gan To Kagaku Ryoho; 1985 Oct; 12(10):1999-2003. PubMed ID: 4051516
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of combination chemotherapy with mitoxantrone, vincristine, prednisolone (MVP) for recurrence of breast cancer].
Iba T; Yagi Y; Kidokoro A; Fukunaga M; Momose F
Gan To Kagaku Ryoho; 1995 Jan; 22(1):83-6. PubMed ID: 7826082
[TBL] [Abstract][Full Text] [Related]
3. Mitoxantrone, 5-fluorouracil and cyclophosphamide in advanced breast cancer.
Martoni A; Rani P; Ercolino L; Canova N; Pannuti F
Chemioterapia; 1988 Oct; 7(5):345-9. PubMed ID: 3224403
[TBL] [Abstract][Full Text] [Related]
4. [Systemic chemotherapy of mammary carcinoma: plasma and tissue concentrations of 5-fluorouracil and adriamycin, and result of CAF and CMF therapy of breast cancer].
Murayama Y; Nagashima M
Gan To Kagaku Ryoho; 1984 Mar; 11(3):415-9. PubMed ID: 6546655
[TBL] [Abstract][Full Text] [Related]
5. [Results of clinical trials with a CMitF (cyclophosphamide, mitoxantrone, and 5-fluorouracil) regimen versus a CAF (cyclophosphamide, adriamycin, and 5-fluorouracil) regimen in advanced/relapsed breast cancer].
Taguchi T; Sakai K; Terasawa T; Wada H
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2820-8. PubMed ID: 3530139
[TBL] [Abstract][Full Text] [Related]
6. A randomized comparison of cyclophosphamide-mitoxantrone-5-fluorouracil v cyclophosphamide-doxorubicin-5-fluorouracil in advanced breast cancer: preliminary observations.
Stewart DJ; Maroun JA; Hirte W; Perrault D; Stolbach L; Cripps C; Lefebvre B
Semin Oncol; 1984 Sep; 11(3 Suppl 1):23-7. PubMed ID: 6385261
[TBL] [Abstract][Full Text] [Related]
7. Mitoxantrone and cyclophosphamide in patients with advanced breast cancer.
Ehninger G; Weible KH; Heidemann EG; Waller HD
Cancer Treat Rep; 1984 Oct; 68(10):1283-4. PubMed ID: 6525600
[TBL] [Abstract][Full Text] [Related]
8. A phase II trial of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisolone rapidly alternating with doxorubicin and vincristine (CMFP/AV) in advanced breast cancer.
Rischin D; Bishop JF; Olver IN; Laidlaw CR; Zimet A; Jeal P; Dipell JF
Am J Clin Oncol; 1992 Oct; 15(5):392-4. PubMed ID: 1524039
[TBL] [Abstract][Full Text] [Related]
9. Clinical effects of combination therapy with mitoxantrone, vincristine, and prednisolone in breast cancer.
Katsumata K; Tomioka H; Kusama M; Aoki T; Koyanagi Y
Cancer Chemother Pharmacol; 2003 Jul; 52(1):86-8. PubMed ID: 12764670
[TBL] [Abstract][Full Text] [Related]
10. [Clinical study of ambulatory cancer chemotherapy for recurrent breast cancer].
Takahashi N; Nitta A; Kunii Y; Ota K
Gan To Kagaku Ryoho; 1994 Dec; 21 Suppl 4():439-43; discussion 443-4. PubMed ID: 7802447
[TBL] [Abstract][Full Text] [Related]
11. Mitomycin C, methotrexate, and vincristine with medroxyprogesterone acetate or prednisolone for doxorubicin resistant advanced breast cancer--a randomized control study.
Tashiro H; Nomura Y
Anticancer Res; 1995; 15(5B):2229-37. PubMed ID: 8572630
[TBL] [Abstract][Full Text] [Related]
12. [Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer].
Abe O; Izuo M; Enomoto K; Kubo K; Koyama H; Sakai K; Terasawa T; Tominaga T; Nomura Y
Gan To Kagaku Ryoho; 1982 May; 9(5):866-73. PubMed ID: 7184431
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) on advanced and recurrent breast cancer. Clinical study group of CMF for breast cancer in Japan].
Nomura Y; Tominaga T; Adachi I; Koyama H; Fukami A
Gan To Kagaku Ryoho; 1994 Sep; 21(12):1949-56. PubMed ID: 8085846
[TBL] [Abstract][Full Text] [Related]
14. [Effects of 4'-Epi-adriamycin, THP-adriamycin and mitoxantrone on patients with advanced and recurrent breast cancer].
Tominaga T; Kitamura M; Hayashi K; Takahashi I; Kosaki G
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1669-74. PubMed ID: 6591857
[TBL] [Abstract][Full Text] [Related]
15. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
[TBL] [Abstract][Full Text] [Related]
16. First-line mitoxantrone chemotherapy for advanced breast cancer.
Wilson KS; Paterson AH
Cancer Treat Rep; 1986 Aug; 70(8):1021-2. PubMed ID: 3731148
[TBL] [Abstract][Full Text] [Related]
17. Mitoxantrone and cyclophosphamide in advanced breast cancer: a pilot study.
McDonald DB; Abu-Zahra H; Yoshida S; Binder H
Semin Oncol; 1984 Sep; 11(3 Suppl 1):19-22. PubMed ID: 6385260
[TBL] [Abstract][Full Text] [Related]
18. [A study on the efficacy of combination chemoendocrine therapy consisting of cyclophosphamide, adriamycin, UFT, and tamoxifen for advanced or recurrent breast cancer].
Yamaguchi S; Fukuda M; Ota T; Nakayama Y; Ogata H; Shimizu K; Nishikawa T; Adachi Y; Fukuma E
Gan To Kagaku Ryoho; 1999 Jul; 26(8):1145-52. PubMed ID: 10431580
[TBL] [Abstract][Full Text] [Related]
19. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
[TBL] [Abstract][Full Text] [Related]
20. [A randomized controlled study of (2'' R)-4'-O-tetrahydropyranyladriamycin and adriamycin in combination with cyclophosphamide and 5-fluorouracil in the treatment of advanced and recurrent breast cancer].
Abe O; Tominaga T; Enomoto K; Abe R; Iino Y; Koyama H; Fujimoto M; Nomura Y; Tanaka T
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2160-8. PubMed ID: 3717960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]